Hiroko Iwamoto

878 total citations
33 papers, 652 citations indexed

About

Hiroko Iwamoto is a scholar working on Molecular Biology, Psychiatry and Mental health and Clinical Biochemistry. According to data from OpenAlex, Hiroko Iwamoto has authored 33 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Psychiatry and Mental health and 8 papers in Clinical Biochemistry. Recurrent topics in Hiroko Iwamoto's work include Epilepsy research and treatment (11 papers), Metabolism and Genetic Disorders (8 papers) and Mitochondrial Function and Pathology (6 papers). Hiroko Iwamoto is often cited by papers focused on Epilepsy research and treatment (11 papers), Metabolism and Genetic Disorders (8 papers) and Mitochondrial Function and Pathology (6 papers). Hiroko Iwamoto collaborates with scholars based in Japan, Pakistan and United States. Hiroko Iwamoto's co-authors include Naruji Sugiyama, Shigeo Kure, Y. Matsubara, Osamu Sakamoto, Shuhei Suzuki, Noriko Aida, Michiko Yamada, Yoshikazu Kuroki, Sumimasa Yamashita and Kimiko Tamagawa and has published in prestigious journals such as The Journal of Pediatrics, Epilepsia and Movement Disorders.

In The Last Decade

Hiroko Iwamoto

31 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Iwamoto Japan 11 383 268 141 120 109 33 652
Paula Garcia Portugal 16 344 0.9× 272 1.0× 162 1.1× 81 0.7× 195 1.8× 49 774
Johann Penzien Germany 14 268 0.7× 184 0.7× 76 0.5× 69 0.6× 72 0.7× 17 627
M. Pineda Spain 13 285 0.7× 127 0.5× 67 0.5× 41 0.3× 118 1.1× 26 533
Emma Footitt United Kingdom 17 387 1.0× 412 1.5× 92 0.7× 106 0.9× 78 0.7× 29 735
Christine Makowski Germany 10 229 0.6× 143 0.5× 51 0.4× 94 0.8× 51 0.5× 18 480
K Naess Sweden 15 740 1.9× 466 1.7× 117 0.8× 41 0.3× 112 1.0× 41 974
I. E. M. Luyt‐Houwen Netherlands 14 866 2.3× 564 2.1× 120 0.9× 54 0.5× 78 0.7× 26 1.1k
Ángeles García‐Cazorla Spain 16 550 1.4× 616 2.3× 129 0.9× 132 1.1× 204 1.9× 37 1.1k
Donald T. Whelan Canada 20 488 1.3× 224 0.8× 101 0.7× 166 1.4× 243 2.2× 42 917
Iris Marquardt Germany 11 347 0.9× 401 1.5× 120 0.9× 76 0.6× 101 0.9× 15 796

Countries citing papers authored by Hiroko Iwamoto

Since Specialization
Citations

This map shows the geographic impact of Hiroko Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Iwamoto more than expected).

Fields of papers citing papers by Hiroko Iwamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Iwamoto. The network helps show where Hiroko Iwamoto may publish in the future.

Co-authorship network of co-authors of Hiroko Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Iwamoto. A scholar is included among the top collaborators of Hiroko Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Iwamoto. Hiroko Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masuda, Takeshi, Kakuhiro Yamaguchi, Shinjiro Sakamoto, et al.. (2025). Two Cases of Epidermal Growth Factor Receptor L861R Mutation‐Positive Lung Adenocarcinoma Treated With Osimertinib and Afatinib. Cancer Reports. 8(12). e70420–e70420.
2.
Osaka, Hitoshi, Shiro Koizume, Hiroko Iwamoto, et al.. (2009). Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation. Brain and Development. 32(9). 703–707. 9 indexed citations
3.
Osaka, Hitoshi, Ikuo Ogiwara, Emi Mazaki, et al.. (2007). Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation. Epilepsy Research. 75(1). 46–51. 32 indexed citations
4.
Saito, Yoshiaki, Hiroko Iwamoto, Akira Matsui, et al.. (2005). Brain MRI findings of older patients with Pallister–Killian syndrome. Brain and Development. 28(1). 34–38. 7 indexed citations
5.
Takahashi, Tatsuya, Nobutaka Arai, Yume Suzuki, et al.. (2005). Autopsy case of acute encephalopathy linked to familial hemiplegic migraine with cerebellar atrophy and mental retardation. Neuropathology. 25(3). 228–234. 16 indexed citations
6.
Li, Min, Natallia Strushkevich, Hiroko Iwamoto, et al.. (2005). Molecular identification of adrenal inner zone antigen as a heme‐binding protein. FEBS Journal. 272(22). 5832–5843. 86 indexed citations
7.
Muto, Ayako, et al.. (2005). Laryngeal dystonia in xeroderma pigmentosum. Brain and Development. 27(8). 598–601. 7 indexed citations
8.
Yamashita, Sumimasa, Hiroko Iwamoto, Masamichi Hara, & Nobutaka Arai. (2002). Infantile spongiform leukoencephalopathy: clinical and neuropathologic findings. Pediatric Neurology. 27(3). 217–220. 3 indexed citations
9.
Nagamitsu, Shinichiro, Toyojiro Matsuishi, Kiyoshi Hashimoto, et al.. (1999). Multicenter study of paroxysmal dyskinesias in Japan?Clinical and pedigree analysis. Movement Disorders. 14(4). 658–663. 28 indexed citations
10.
Tanaka, Yukichi, Mitsuo Masuno, Hiroko Iwamoto, et al.. (1999). Noonan syndrome and cavernous hemangioma of the brain. American Journal of Medical Genetics. 82(3). 212–214. 10 indexed citations
11.
Kure, Shigeo, Hiroko Iwamoto, Shuhei Suzuki, et al.. (1999). Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. The Journal of Pediatrics. 135(3). 375–378. 245 indexed citations
12.
Kuroda, Yasuhiro, Michinori Ito, Ichiro Yokota, et al.. (1997). Concomitant administration of sodium dichloroacetate and vitamin B1 for lactic acidemia in children with MELAS syndrome. The Journal of Pediatrics. 131(3). 450–452. 19 indexed citations
13.
Shuto, Takashi, et al.. (1996). Rapidly growing calcified cerebellar astrocytoma in infants. Child s Nervous System. 12(2). 107–109. 3 indexed citations
14.
Kimura, Seiji, Takuya Kobayashi, Yukichi Tanaka, et al.. (1993). Fukuyama-type congenital muscular dystrophy and the Walker-Warburg syndrome. Brain and Development. 15(3). 182–191. 25 indexed citations
15.
Awaya, Yutaka, Hiroko Iwamoto, & Yukio Fukuyama. (1992). A Long‐Term Follow‐Up Study of First Episodes of Idiopathic Status Convulsivus in Childhood: In Relation to Subsequent Epilepsy (Second Report). Psychiatry and Clinical Neurosciences. 46(2). 303–306. 7 indexed citations
16.
Kimura, Seiji, Takuya Kobayashi, Yuka Sasaki, et al.. (1992). Congenital Polyneuropathy in Walker-Warburg Syndrome. Neuropediatrics. 23(1). 14–17. 5 indexed citations
17.
Yamashita, Sumimasa, et al.. (1991). Schoolchildren with Epilepsy: Epidemiological and Longitudinal Studies on Questionnaire for Teachers at Intervals of 12 Years. Psychiatry and Clinical Neurosciences. 45(2). 487–489. 3 indexed citations
18.
Yamada, Michiko, et al.. (1988). Comprehensive Management of Children with Epilepsy—From Standpoint of a Medical Practitioner in Children's Hospital. Psychiatry and Clinical Neurosciences. 42(3). 467–471. 1 indexed citations
19.
Yamashita, Sumimasa, et al.. (1987). A Clinical and EEG Study of Predominantly Unilateral Seizures in Children–Comparison with Severe Myoclonic Epilepsy in Infancy. Psychiatry and Clinical Neurosciences. 41(3). 470–474. 3 indexed citations
20.
Tatsuno, Masami, et al.. (1984). [Autopsy case of Leigh's encephalopathy with wide lesions in central nervous system and early infantile epileptic encephalopathy with burst suppression].. PubMed. 16(1). 68–75. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Garcia Breakdown of academic impact, for papers by Johann Penzien Breakdown of academic impact, for papers by M. Pineda Breakdown of academic impact, for papers by Emma Footitt Breakdown of academic impact, for papers by Christine Makowski Breakdown of academic impact, for papers by K Naess Breakdown of academic impact, for papers by I. E. M. Luyt‐Houwen Breakdown of academic impact, for papers by Ángeles García‐Cazorla Breakdown of academic impact, for papers by Donald T. Whelan Breakdown of academic impact, for papers by Iris Marquardt
Rankless by CCL
2026